Opportunistic infections associated with Janus kinase inhibitor treatment for rheumatoid arthritis: A structured literature review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Opportunistic infections associated with Janus kinase inhibitor treatment for rheumatoid arthritis: A structured literature review

Published:2023-02 Issue: Volume:58 Page:152120
ISSN:0049-0172
Container-title:Seminars in Arthritis and Rheumatism
language:en
Short-container-title:Seminars in Arthritis and Rheumatism

Author:

Winthrop Kevin,Isaacs John,Calabrese Leonard,Mittal Deepali,Desai Supriya,Barry Jane,Strengholt Sander,Galloway James

Publisher

Elsevier BV

Subject

Anesthesiology and Pain Medicine,Rheumatology

Reference67 articles.

1. JAK inhibitors for the treatment of rheumatoid arthritis;Morinobu;Immunol Med,2020

2. A systematic review and meta-analysis of infection risk with small molecule JAK inhibitors in rheumatoid arthritis;Bechman;Rheumatology,2019

3. JAK inhibitors in rheumatoid arthritis: an evidence-based review on the emerging clinical data;Harrington;J Inflamm Res,2020

4. FDA approves tofacitinib for rheumatoid arthritis;Traynor;Am J Health Syst Pharm,2012

5. FDA approves xeljanz,2012

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cumulative incidence and risk of infection in patients with rheumatoid arthritis treated with janus kinase inhibitors: A systematic review and meta-analysis;PLOS ONE;2024-07-31

2. A double-edged sword: unusual multiple severe infections with pralsetinib: a case report and literature review;Frontiers in Medicine;2024-07-30

3. Preventing herpes zoster in immunocompromised patients: Current concepts;Cleveland Clinic Journal of Medicine;2024-07

4. Determination of Enantiomer in Tofacitinib Citrate Using Reversed-Phase Chiral High-Performance Liquid Chromatography;Separations;2024-03-21

5. Cervical lymphadenitis caused by Mycobacterium avium in a patient treated with Janus kinase inhibitors;International Journal of Infectious Diseases;2023-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3